← All Evommune, INC filings

Evommune, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NYSE
EVMN
Evommune, INC
SCHEDULE: Point72 Discloses 5.3% Stake in Evommune
Point72 Asset Management, L.P., along with affiliated entities and Steven A. Cohen, has reported beneficial ownership of 5.3% of Evommune, Inc.'s common stock as of July 15, 2026.
NYSE
EVMN
Evommune, INC
SCHEDULE: Nan Fung Group Discloses Significant Evommune Stake
Nan Fung Group Holdings Limited and its affiliated entities have disclosed beneficial ownership of up to 10.9% of Evommune, Inc.'s common stock.